After Hours Summary: IONS -19.4% falls on Roche discontinuing dosage; BLFS +12% jumps on earnings and acquisition; DSP -9.8%, RAVN -9.6% fall on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: BLFS +12% (also to acquire Stirling Ultracold in all-stock deal)
Companies trading higher in after hours in reaction to news: PMBC +22.8% (BANC to merge with PMBC), CHMA +10.5% (presents data from extension of Phase 3 CHIASMA OPTIMAL study), NEWT +3.8% (increases dividend and reports earnings), KODK +3.4% (partners with German printing firm ONLINEPRINTERS Group), PTGX +2.9% (intends to initiate Phase 3 trial of rusfertide in PV after feedback from FDA and EMA), EHTH +2.8% (Starboard Value discloses 6.9% active stake), BOWX +1.3% (WeWork lost $3.2 bln last year, according to FT), MITT +0.7% (increases dividend), ZEAL +0.7% (FDA approves Zegalogue injection for severe hypoglycemia in diabetes patients), GOOG +0.2% (Google Cloud hires former INTC exec Uri Frank as VP of Engineering for server chip design), PSN +0.1% (awarded $250 mln Naval Information Warfare Center contract), ACA +0.1% (to acquire StonePoint Ultimate for $375 mln in cash), ETN +0.1% (acquires Green Motion, a supplier of EV charging hardware and software), SINA +0.1% (completes merger transaction with New Wave Holdings), BANC +0.1% (BANC to merge with PMBC), MSFT +0.1% (rebranding Xbox Live to Xbox network, according to TheVerge)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: DSP -9.8%, RAVN -9.6%
Companies trading lower in after hours in reaction to news: IONS -19.4% (partner Roche discontinued dosing in their manifest Huntington's disease trial), ANIX -17.5% (announces bought deal offering of 1,904,762 shares priced at $5.25/sh), XGN -8.5% (stock offering), QS -7.7% (stock offering), PLL -6.2% (stock offering), AVEO -5.9% (stock offering), MP -5.7% (stock offeirng and convertible notes offering), VIAC -3.5% (stock offering), WES -3% (stock offering), HUIZ -2.1% (stock offering), NVO -1.5% (says FDA has issued a Refusal to File letter covering the label expansion for semaglutide 2.0 mg for the treatment of type 2 diabetes), DSKE -0.5% (authorizes repurchase of 3 mln shares), AAPL -0.2% (sensor for temperature and humidity could revive smart home strategy, according to Bloomberg)